The Role of Cold Rooms in Personalized Medicine Storage

In the era of modern healthcare, personalized medicine is transforming the way treatments are developed and delivered. Tailored to individual patients based on their genetic profile, lifestyle, or specific medical needs, these therapies offer precision and effectiveness that traditional treatments often lack. However, the success of personalized medicine depends not only on scientific breakthroughs but also on precise and reliable storage solutions.

Among the critical elements in this storage infrastructure are cold rooms—engineered spaces that maintain consistent, controlled environments for sensitive medical products. These cold rooms play a central role in safeguarding the temperature integrity of individualized therapies, supporting rapid production, and protecting custom-compounded treatments throughout their lifecycle.

This article explores how cold room design and functionality align with the demanding requirements of personalized medicine, supported by real-world examples and best practices.

1. Special Temperature Needs for Individualized Therapies

Unlike mass-produced drugs, personalized therapies—such as gene therapies, CAR-T cell treatments, and custom-compounded formulations—are biologically delicate and often have narrow temperature tolerance ranges. Many must be stored at 2°C to 8°C, while others require -20°C or ultra-low temperatures as low as -80°C to maintain stability and efficacy.

The risk of degradation due to even slight fluctuations in temperature is high. For example:

• CAR-T cell therapies, derived from a patient’s own cells, must be preserved at ultra-low temperatures throughout production and transport.

• mRNA-based treatments, like some cancer vaccines, are particularly unstable at room temperature and require strict thermal control.

• Personalised hormone therapies or paediatric medicines may include components that degrade rapidly without refrigeration.

Cold rooms must therefore be equipped with precise temperature monitoring, redundancy systems, and fail-safes to avoid any interruptions that could compromise these high-value products.

2. How Cold Room Design Supports Rapid Patient-Specific Production

Speed is essential in the production and distribution of personalized medicine. The entire process—from lab to patient—often takes just days or even hours. Cold rooms must be designed to enable fast turnaround, easy access, and seamless integration with production spaces.

Key design elements include:

• Strategically placed doors and airlocks to allow quick transfers without temperature disruptions.

• Compact, modular layouts that bring cold storage close to the compounding or cleanroom areas.

• Real-time digital monitoring systems for temperature and humidity, ensuring immediate alerts for any deviation.

• Storage flexibility for small-batch or single-patient doses, with adjustable racking and labelled compartments.

Case Study:
In 2023, Kiat Lay collaborated with a cell therapy lab in Singapore to develop a cold room adjacent to its production suite. The room was equipped with dual temperature zones (2–8°C and -80°C), rapid-close insulated doors, and IoT-linked alarms. This layout allowed the lab team to store therapies immediately after processing, maintaining critical temperatures during preparation and shipping—all within the same facility. As a result, turnaround time improved by 30%, and zero batch losses occurred in the following 12 months.

3. Protecting Product Integrity During Custom Compounding

Custom compounding—the preparation of medicines tailored for individual patients—often involves ingredients with short shelf lives and strict storage conditions. Whether it’s a paediatric antibiotic in a liquid form or a personalised hormone blend, maintaining the integrity of active ingredients is crucial.

Cold rooms serving compounding pharmacies must include:

• Hygienic surfaces compliant with GMP (Good Manufacturing Practice) standards.

• Temperature-zoned areas for storing raw ingredients and finished products separately.

• Controlled humidity systems to prevent moisture-related degradation.

• Filtered airflow and ventilation to minimise contamination risks.

Example:
A private hospital in Singapore sought a reliable storage system for its in-house pharmacy, which compounded medications for cancer and paediatric patients. Kiat Lay installed a pharmaceutical-grade cold room with dual-zone cooling, integrated dehumidifiers, and a transparent door logging system. This setup allowed pharmacists to monitor product access and storage conditions in real time, reducing waste by over 20% and passing all regulatory audits without issue.

4. Cold Rooms as a Regulatory Compliance Solution

Personalized medicine requires not only innovation but also adherence to strict regulatory standards. Health authorities such as Singapore’s Health Sciences Authority (HSA), Malaysia’s National Pharmaceutical Regulatory Agency (NPRA), and international organisations like the WHO and EMA demand documented temperature control, traceability, and validated equipment for any facility handling such products.

Kiat Lay cold rooms are designed to support compliance with:

• Good Distribution Practice (GDP) and Good Manufacturing Practice (GMP) standards.

• Temperature mapping and validation protocols.

• Continuous data logging, with audit trails and remote access.

• Backup systems, including secondary refrigeration and emergency power, to guarantee uninterrupted storage.

These features not only help pharmaceutical facilities meet compliance requirements but also safeguard against product recalls and financial loss.

5. Looking Ahead: Cold Chain Innovation for Personalized Medicine

As the healthcare industry continues its shift toward individualized care, cold room technology must also evolve. The future will likely bring:

• Smarter cold rooms with AI-driven predictive maintenance and temperature forecasting.

• Automated storage retrieval systems (ASRS) for precise inventory control.

• Mobile modular cold rooms, deployable near hospitals or research centres to reduce transport time.

Kiat Lay is actively exploring and implementing many of these features across Southeast Asia, providing our partners with future-proof infrastructure that aligns with medical innovation.

Conclusion

Personalized medicine represents the future of healthcare—but it cannot succeed without the right support systems. Cold rooms are more than storage spaces; they are critical enablers of fast, safe, and compliant treatment delivery. They protect delicate formulations, ensure rapid patient-specific processing, and form the backbone of temperature-sensitive workflows.

At Kiat Lay, we are proud to lead in the design and implementation of pharmaceutical cold rooms tailored to the specific needs of personalized medicine. Whether you’re developing cell therapies, compounding drugs on-site, or building a facility from scratch, we offer end-to-end solutions that prioritise reliability, precision, and regulatory readiness.

🔹 Learn more about our cold room solutions at www.kiatlay.com.sg